Associated Papers
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis.
Urso L et al.
Frontiers in Oncology, 2021
Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis.
Zhang K et al.
Cancer Management and Research, 2018
Select a paper to view details